B6;129-Mapkapk2tm1Gkl/Flmg
Status | Available to order |
EMMA ID | EM:10944 |
International strain name | B6;129-Mapkapk2tm1Gkl/Flmg |
Alternative name | MK2FLneo/FLneo [129.B6-MapkapK2tm1Gkl/Flmg] |
Strain type | Targeted Mutant Strains : Conditional mutation |
Allele/Transgene symbol | Mapkapk2tm1Gkl, |
Gene/Transgene symbol | Mapkapk2 |
Information from provider
Provider | George Kollias |
Provider affiliation | BSRC Fleming |
Genetic information | MK2FLneo mice contain loxP sites 1/2 flanking a neomycin resistance gene fragment and loxP sites 2/3 flanking the area between exons 2-5 of the mouse Mapkapk2 gene. |
Phenotypic information | Homozygous:No overt phenotypeHeterozygous:No overt phenotype |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | B.S.R.C. Alexander Fleming, Vari, Greece |
Animals used for archiving | homozygous C57BL/6 |
Literature references
- Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis.;Henriques Ana, Koliaraki Vasiliki, Kollias George, ;2018;Proceedings of the National Academy of Sciences of the United States of America;115;E5546-E5555; 29844172
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).